Adcytherix Overview
- Year Founded
-
2024

- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$32.5M
- Investors
-
6
Adcytherix General Information
Description
Operator of a biopharmaceutical company intended to develop novel antibody drug conjugates to treat cancer. The company offers drugs to treat unmet-need diseases, enabling healthcare industries to improve patient treatment and outcomes.
Contact Information
Website
www.adcytherix.comCorporate Office
- 17 Boulevard Augustin Cieussa
- 13007 Marseille
- France
Corporate Office
- 17 Boulevard Augustin Cieussa
- 13007 Marseille
- France
Adcytherix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Seed Round | 11-Jun-2024 | $32.5M | Completed | Generating Revenue |
Adcytherix Comparisons
Industry
Financing
Details
Adcytherix Competitors (46)
One of Adcytherix’s 46 competitors is Iovance Biotherapeutics, a Corporation company based in San Carlos, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
Oxford Biotherapeutics | Private Equity-Backed | Oxford, United Kingdom | ||||
CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
Meditope Biosciences | Venture Capital-Backed | Pasadena, CA | ||||
Cantex Pharmaceuticals | Formerly VC-backed | Weston, FL |
Adcytherix Patents
Adcytherix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2024210894-A1 | Ecteinascidin derivative antibody drug conjugates | Pending | 17-Jan-2023 |
Adcytherix Signals
Adcytherix Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Dawn Biopharma | Corporation | Minority | ||
Kinled Holding | Family Office | Minority | ||
Pontifax Venture Capital | Venture Capital | Minority | ||
Pureos Bioventures | Venture Capital | Minority | ||
RA Capital Management | Venture Capital | Minority |
Adcytherix FAQs
-
When was Adcytherix founded?
Adcytherix was founded in 2024.
-
Where is Adcytherix headquartered?
Adcytherix is headquartered in Marseille, France.
-
What is the size of Adcytherix?
Adcytherix has 10 total employees.
-
What industry is Adcytherix in?
Adcytherix’s primary industry is Drug Discovery.
-
Is Adcytherix a private or public company?
Adcytherix is a Private company.
-
What is the current valuation of Adcytherix?
The current valuation of Adcytherix is
. -
What is Adcytherix’s current revenue?
The current revenue for Adcytherix is
. -
How much funding has Adcytherix raised over time?
Adcytherix has raised $32.5M.
-
Who are Adcytherix’s investors?
Dawn Biopharma, Kinled Holding, Pontifax Venture Capital, Pureos Bioventures, and RA Capital Management are 5 of 6 investors who have invested in Adcytherix.
-
Who are Adcytherix’s competitors?
Iovance Biotherapeutics, Oxford Biotherapeutics, CytomX Therapeutics, Meditope Biosciences, and Cantex Pharmaceuticals are some of the 46 competitors of Adcytherix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »